Therapy News and Research

RSS

FDA expands approval of smaller size replacement heart valve for treating newborn pediatric patients

The U.S. Food and Drug Administration today expanded the approval of a heart valve to include a size small enough to be used in newborn pediatric patients to treat heart defects. Specifically, the agency approved the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff to include the 15-mm valve size, making it the smallest mechanical heart valve approved in the world.

7 Mar 2018

Individual damaged nerve cells cause neurodegenerative diseases

If the sense of smell disappears, this can indicate a disease such as Alzheimer's or Parkinson's disease. However, unlike previously assumed, general degenerations in the nervous system do not play a leading role in the loss of the sense of smell with increasing age, but individual nerve cells or classes of nerves are decisive.

7 Mar 2018

FDA approves new antiretroviral medication for patients with multidrug-resistant HIV

Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV).

6 Mar 2018

Innovative antibody delivery method could offer effective way to combat Ebola infection

More than 11,000 people died during the Ebola outbreak in West Africa from 2013-16, demonstrating both the deadly nature of the virus and the limitations of the medication used to fight it.

6 Mar 2018

Research identifies new biomarkers for future dementia risk

Sudha Seshadri, M.D., founding director of the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases at UT Health San Antonio, is co-leader and senior author on research announced March 6 that identifies novel biomarkers of risk for future dementia.

6 Mar 2018

Duke scientists pinpoint new therapeutic target for macular degeneration

Duke Researchers have pinpointed a new therapeutic target for macular degeneration, an eye disease that affects over 10 million Americans and is the leading cause of blindness in adults over 60.

6 Mar 2018

Preventing metabolic exhaustion in immune cells could enhance effects of immunotherapy

If you're an immune cell gearing up to fight cancer, you'd better eat your breakfast. The tumor microenvironment is a harsh place, and tumor cells are ready to wear you out.

6 Mar 2018

Physicians create long-awaited baseline measure of pelvic organ prolapse progression

By measuring the sagging of the vaginal walls in more than a thousand volunteers for up to nine years annually, a team of Baltimore physicians reports the creation of a long-awaited baseline measure of the rate of progression of so-called pelvic organ prolapse.

6 Mar 2018

Gene-editing technology enhances T cell immunotherapies for treating cancer

Last year, the Food and Drug Administration approved the first cellular immunotherapies to treat cancer. These therapies involve collecting a patient's own immune cells -- called T cells -- and supercharging them to home in on and attack specific blood cancers, such as hard-to-treat acute lymphoblastic leukemia and non-Hodgkin lymphoma.

6 Mar 2018

Researchers aim to to better predict future chronic opioid therapy in hospital patients

Researchers at the University of Colorado Anschutz Medical Campus are working to develop statistical models to better predict which patients will be prescribed opioid medications long-term following discharge from a hospital stay.

6 Mar 2018

Neurocognitive deficits worsen outcomes for joint replacement surgery, finds study

Patients with undiagnosed neurocognitive deficits are more likely to undergo joint replacement surgeries and suffer worse outcomes, finds study.

6 Mar 2018

Levels of inflammatory biomarkers could predict effectiveness of ECT for people with depression

People with major depression that has not been well controlled by medications and who have a biomarker in their blood indicating a higher level of inflammation may benefit more than people with less inflammation from electroconvulsive therapy to ease symptoms of their depression, according to a new UCLA study.

6 Mar 2018

One-month antibiotic regimen to prevent TB as safe, effective as nine-month therapy for HIV patients

A one-month antibiotic regimen to prevent active tuberculosis (TB) disease was at least as safe and effective as the standard nine-month therapy for people living with HIV, according to the results of a large international clinical trial.

6 Mar 2018

Researchers develop gene therapy that treats a form of macular degeneration in canine model

Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model.

6 Mar 2018

UNC Lineberger study identifies genetic clues that explain how breast cancer metastasizes

Breast cancer is the second leading cause of cancer death in women in the United States, with most deaths caused by the cancer spreading beyond the breast.

6 Mar 2018

Restoring lipid synthesis could slow progression of pulmonary fibrosis

Pulmonary fibrosis, an ongoing process of scarring that leaves patients chronically short of breath, can progress in severity until the only course of treatment is lung transplant.

6 Mar 2018

Multimodal treatment approach enhances long-term survival in men with metastatic prostate cancer

UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate in men with aggressive prostate cancer.

5 Mar 2018

Plymouth researcher receives grant to further investigate causes of hereditary neuro-tumors

The University of Plymouth will be continuing its research into the advancement of neuro-tumor treatments thanks to more than £100,000 from Great Ormond Street Hospital Children's Charity and Sparks, the medical research charity.

5 Mar 2018

NETRF awards six new research grants to improve treatments for neuroendocrine tumors

The Neuroendocrine Tumor Research Foundation today awarded six new research grants totaling $1.85 million to leading academic institutions around the world.

5 Mar 2018

While talk about opioids continues in DC, addiction treatment is in peril in states

Opioids were on the White House agenda Thursday — President Trump convened a summit with members of his administration about the crisis. And Congress authorized funds for the opioid crisis in its recent budget deal — but those dollars aren’t flowing yet, and states say they are struggling to meet the need for treatment.

5 Mar 2018

Therapy News and Research

FDA expands approval of smaller size replacement heart valve for treating newborn pediatric patients

Individual damaged nerve cells cause neurodegenerative diseases

FDA approves new antiretroviral medication for patients with multidrug-resistant HIV

Innovative antibody delivery method could offer effective way to combat Ebola infection

Research identifies new biomarkers for future dementia risk

Duke scientists pinpoint new therapeutic target for macular degeneration

Preventing metabolic exhaustion in immune cells could enhance effects of immunotherapy

Physicians create long-awaited baseline measure of pelvic organ prolapse progression

Gene-editing technology enhances T cell immunotherapies for treating cancer

Researchers aim to to better predict future chronic opioid therapy in hospital patients

Neurocognitive deficits worsen outcomes for joint replacement surgery, finds study

Levels of inflammatory biomarkers could predict effectiveness of ECT for people with depression

One-month antibiotic regimen to prevent TB as safe, effective as nine-month therapy for HIV patients

Researchers develop gene therapy that treats a form of macular degeneration in canine model

UNC Lineberger study identifies genetic clues that explain how breast cancer metastasizes

Restoring lipid synthesis could slow progression of pulmonary fibrosis

Multimodal treatment approach enhances long-term survival in men with metastatic prostate cancer

Plymouth researcher receives grant to further investigate causes of hereditary neuro-tumors

NETRF awards six new research grants to improve treatments for neuroendocrine tumors

While talk about opioids continues in DC, addiction treatment is in peril in states

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News